Question 1

What is the purpose of this trial and how might it benefit me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC clinical trial (NCT03912389). Contact the study team or your healthcare provider for specific answers.

Question 2

How does BCD-100 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC clinical trial (NCT03912389). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC clinical trial (NCT03912389). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC clinical trial (NCT03912389). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC clinical trial (NCT03912389). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC clinical trial (NCT03912389). Contact the study team or your healthcare provider for specific answers.

What this study is about